The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study

Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration–resistant prostate cancer

(2015) Rhonda L. Bitting et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Molecular profiling of single circulating tumor cells with diagnostic intention

(2014) B. Polzer et al.   EMBO Molecular Medicine

Circulating tumour cells—monitoring treatment response in prostate cancer

(2014) David T. Miyamoto et al.   Nature Reviews Clinical Oncology

AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

(2014) Emmanuel S. Antonarakis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

(2014) M. Yu et al.   SCIENCE

Validation and clinical utility of prostate cancer biomarkers

(2013) Howard I. Scher et al.   Nature Reviews Clinical Oncology

Circulating tumor cells and DNA as liquid biopsies

(2013) Ellen Heitzer et al.   Genome Medicine

Circulating Tumor Cells in Prostate Cancer

(2013) Brian Hu et al.   Cancers

Challenges in the Enumeration and Phenotyping of CTC

(2012) F. A. W. Coumans et al.   CLINICAL CANCER RESEARCH

Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer

(2012) C. Gasch et al.   CLINICAL CHEMISTRY

Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device

(2012) Brian J. Kirby et al.   PLoS One

Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links

(2012) Christina Scheel et al.   SEMINARS IN CANCER BIOLOGY

Circulating Epithelial Cells in Patients with Benign Colon Diseases

(2011) K. Pantel et al.   CLINICAL CHEMISTRY

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

(2011) Daniel C. Danila et al.   EUROPEAN UROLOGY

High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

(2010) Sarah Minner et al.   PROSTATE

Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer

(2010) S. L. Stott et al.   Science Translational Medicine

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody

(2009) Jason P. Gleghorn et al.   LAB ON A CHIP

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

(2009) Howard I Scher et al.   LANCET ONCOLOGY

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

(2008) D. Olmos et al.   ANNALS OF ONCOLOGY

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH